Showing results (171-180 of 201) with videos related to
Sort By:
Pageof 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of ageC Hosing, R M Saliba, G-J Okoroji, et al.Blood|December 1, 1996
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantationD Przepiorka, C Ippoliti, I Khouri, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 1, 1997
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patientsK van Besien, P Thall, M Korbling, et al.Bone Marrow Transplantation|May 21, 2008
Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric populationJ E Levine, A J Barrett, M-J Zhang, et al.Blood|December 1, 1995
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantationS Giralt, J Hester, Y Huh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantationR H Collins, O Shpilberg, W R Drobyski, et al.Bone Marrow Transplantation|October 12, 1999
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantationD Przepiorka, I Khouri, C Ippoliti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphomaD Przepiorka, K van Besien, I Khouri, et al.Blood|August 10, 1999
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantationD Przepiorka, T L Smith, J Folloder, et al.American Journal of Hematology|July 10, 2001
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemiaS Bibawi, D Abi-Said, L Fayad, et al.Pageof 21